BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/88/0.1/20.12.24 | Market Closed - Börse Stuttgart 02:43:52 2024-07-17 am EDT | ||
| 0.72 EUR | -13.25% |
|
| Current month | -36.28% | ||
| 1 month | -7.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 0.72 | -13.25% |
| 24-07-16 | 0.83 | -10.75% |
| 24-07-15 | 0.93 | -13.08% |
| 24-07-12 | 1.07 | -6.96% |
| 24-07-11 | 1.15 | +4.55% |
Delayed Quote Börse Stuttgart
Last update July 17, 2024 at 02:43 am EDT
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD4BFP |
| ISIN | DE000VD4BFP6 |
| Date issued | 2024-04-16 |
| Strike | 88 $ |
| Maturity | 2024-12-20 (156 Days) |
| Parity | 10 : 1 |
| Emission price | 1.09 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.22 € |
|---|---|
| Lowest since issue | 0.71 € |
| Spread | 0.01 € |
| Spread % | 1.39% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.31
USD
Average target price
96.46
USD
Spread / Average Target
+10.48%
- Stock Market
- Warrants
- Warrant
